Journal Information

Statistics

Follow this link to access the full text of the article

Original article
A Phase Ib open label, randomized, safety study of SANGUINATE™ in patients with sickle cell anemia
Hemant Misraa,
Corresponding author
hmisra@prolongpharma.com

Corresponding author at: Clinical Development, 300B Corporate Court, South Plainfield, NJ 07080, United States.
, James Bainbridgea, John Berrymana, Abraham Abuchowskia, Kenneth Mauricio Galvezb, Luis Fernando Uribec, Angel Luis Hernandezd, Nestor Rodolfo Sosae
a Prolong Pharmaceuticals, South Plainfield, United States
b Hospital Pablo Tobon Uribe, Medellin, Colombia
c Fundación Reina Isabel, Cali, Colombia
d Fundación BIOS, Barranquilla, Colombia
e Pan American Medical Research Institute, Pamri, Panama
Read
2100
Times
was read the article
594
Total PDF
1506
Total HTML
Share statistics
Article information
ISSN: 15168484
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 April 38 17 55
2025 March 62 14 76
2025 February 57 29 86
2025 January 44 21 65
2024 December 33 18 51
2024 November 57 24 81
2024 October 227 22 249
2024 September 71 23 94
2024 August 50 23 73
2024 July 69 25 94
2024 June 44 30 74
2024 May 213 20 233
2024 April 46 23 69
2024 March 41 20 61
2024 February 47 29 76
2024 January 73 28 101
2023 December 59 31 90
2023 November 76 54 130
2023 October 45 38 83
2023 September 44 39 83
2023 August 19 15 34
2023 July 22 15 37
2023 June 28 14 42
2023 May 28 14 42
2023 April 13 8 21
Show all

Follow this link to access the full text of the article

Idiomas
Hematology, Transfusion and Cell Therapy